Latest National Comprehensive Cancer Network Stories

2013-10-29 23:29:58

The First Annual JADPRO LIVE Conference to feature a special panel discussion on the changing role of advanced practitioners in oncology, today and tomorrow. Cold Spring Harbor, NY (PRWEB) October 29, 2013 Harborside Press is pleased to announce its first annual three-day conference, JADPRO LIVE: Transforming Oncology Practice. The conference brings Harborside’s popular peer-reviewed publication, the Journal of the Advanced Practitioner in Oncology (JADPRO), to a live, interactive...

2013-09-23 13:58:38

Cancer patients receiving radiotherapy (RT) who are potentially suffering from depression can be effectively identified by a two-item questionnaire, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. The Radiation Oncology Therapy Group (RTOG) Community Clinical Oncology Program (CCOP)-supported multi-institutional study screened 455 patients receiving radiation treatment at 37 centers around the U.S. Participants in the...

2013-08-05 23:04:19

A new drug is being developed to help patients suffering from the undertreated cancer mesothelioma LOS ANGELES (PRWEB) August 05, 2013 Baron and Budd is proud to announce the Food and Drug Administration’s approval of a new drug to be used for the treatment of the rare cancer, mesothelioma, that occurs because of exposure to asbestos. This new drug is called VS-6036, or defactinib, and is a cancer-stem-cell inhibitor that is manufactured by Verastem Inc. (VSTM)....

2013-07-22 23:17:18

New Edition Features Updated Treatment Information and Comprehensive Resources for Mesothelioma Patients Los Angeles, CA (PRWEB) July 22, 2013 The national mesothelioma law firm of Baron and Budd has once again partnered with CURE Media Group to produce the 2nd Edition of Understanding Mesothelioma. The updated version of the popular publication now includes information on both peritoneal and pleural mesothelioma. The book is vibrantly illustrated and provides a widespread synopsis of...

2013-05-31 23:20:22

Cancer center, biopharmaceutical company partner on preclinical testing of investigational agent that has shown promise against solid tumors, blood cancers. Agent, a PIM inhibitor, targets a class of enzymes that help to regulate cancer cell survival. Buffalo, N.Y. (PRWEB) May 31, 2013 A new partnership, first of its kind for both organizations, will see Roswell Park Cancer Institute (RPCI) and Jasco Pharmaceuticals, LLC collaborating to advance development of an investigational...

2013-05-24 23:18:09

Recent AllMed webinar summarized recent National Cancer Care Network updates for breast, colon, lunch and thyroid cancer care, which featured changes and additions to screening, workup and treatment. Portland, OR (PRWEB) May 24, 2013 The NCCN Guidelines are “the backbone for determining medical care for patients with cancer,” according to Dr. Devon Webster, a medical oncologist and Associate Medical Director at AllMed Healthcare Management. During a recent webinar for health...

Word of the Day
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.